E. Bel (Leiden, The Netherlands), E. Irusen (Tygerberg, South Africa)
High BMI in severe asthma is associated with co-morbid factors but not with increased airway inflammation or -obstruction
I. H. Van Veen, M. C. Timmers, E. H. Bel, A. ten Brinke (Leiden, Leeuwarden, The Netherlands)
|  |
Significance of persistent airflow obstruction in patients with severe asthma
D. Bumbacea, D. Campbell, D. S. Robinson, K. F. Chung (London, United Kingdom; Bucharest, Romania)
| |
Treatment of moderate to severe asthma with ciclesonide: a long-term investigation over 52 weeks
B. J. O'Connor, S. Kilfeather, D. Cheung, P. Sips, M. D. Blagden, H. Kafé, C. Biberger (London, Sunderland, Chesterfield, United Kingdom; Schiedam, Utrecht, The Netherlands; Saint Quentin, France; Konstanz, Germany)
| |
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
S. Nakajima, Y. Tohda, M. Fujimura, H. Taniguchi, K. Takagi, T. Igarashi, H. Yasuhara, K. Takahashi (Japan)
| |
Mometasone furoate reduces oral corticosteroid requirements and permits recovery of hypothalamic-pituitary-adrenal axis function in patients with severe persistent asthma
J. P. Karpel, W. Lumry, E. Kerwin (Bronx, Dallas, Medford, United States Of America)
| |
Montelukast in cases of severe asthma
J. C. Magariños, R. García Yanneo (Montevideo, Uruguay)
| |
The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma
A. Dor, M. Krasnowska, E. Passowicz, H. Nowosad, E. Marszalek, M. Malolepszy (Wroclaw, Poland)
| |